vTv Therapeutics Inc. 8-K

What Happened

• vTv Therapeutics Inc. (VTVT) filed a Form 8-K on May 13, 2026 (Item 2.02) to furnish a press release announcing its financial results for the fiscal period ended March 31, 2026.
• The press release is attached as Exhibit 99.1 to the 8-K. The report was signed by Paul J. Sekhri, President and Chief Executive Officer.
• The company notes the furnished information (including Exhibit 99.1) is not “filed” under Section 18 of the Exchange Act and is not automatically incorporated by reference into other registration statements or filings.

Key Details

• Filing date: May 13, 2026 (Form 8-K).
• Reporting period: fiscal quarter ended March 31, 2026.
• Exhibit attached: Press Release dated May 13, 2026 (Exhibit 99.1).
• Administrative note: Interactive XBRL cover page/Inline XBRL file included (Exhibit 104); information furnished, not filed, per the company.

Why It Matters

• This 8-K signals vTv has released its latest quarterly financial results (earnings/quarterly results). Investors should read the attached press release for specific figures—revenue, net income/loss, cash position and any management commentary—because these metrics affect valuation and near-term outlook.
• The filing itself is a routine disclosure step; because the press release is furnished (not filed), investors should also watch for any subsequent Form 10-Q or additional filings that formally present the detailed financial statements and management discussion.